Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Journal of Gastroenterology|July 2, 2008
Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantationMasatoshi Ishigami, Takashi Honda, Akihiko Okumura, et al.
Oncology|May 4, 2018
Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib TreatmentTeiji Kuzuya, Masatoshi Ishigami, Yoji Ishizu, et al.
Clinical Journal of Gastroenterology|April 28, 2017
Utility of Doppler ultrasonography for diagnosing and assessing treatment effects in liver compartment syndromeYusuke Ando, Masatoshi Ishigami, Yoji Ishizu, et al.
Journal of Medical Virology|November 30, 2006
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1BMutsumi Murayama, Yoshiaki Katano, Isao Nakano, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 27, 2022
Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosisYoji Ishizu, Masatoshi Ishigami, Takashi Honda, et al.
Nutrition and Cancer|March 14, 2022
Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective StudyTakafumi Yamamoto, Norihiro Imai, Teiji Kuzuya, et al.
Digestive Diseases (Basel, Switzerland)|March 28, 2022
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|September 21, 2021
Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated ComplicationsMasatoshi Ishigami, Takashi Honda, Yoji Ishizu, et al.
European Journal of Gastroenterology & Hepatology|November 6, 2019
Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver diseaseTakanori Ito, Masatoshi Ishigami, Yoji Ishizu, et al.
Springerplus|September 7, 2013
Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiologyMasatoshi Ishigami, Yoji Ishizu, Yasuharu Onishi, et al.
Pageof 30